Transcriptomic profiling of early synucleinopathy in rats induced with preformed fibrils

Examination of early phases of synucleinopathy when inclusions are present, but long before neurodegeneration occurs, is critical to both understanding disease progression and the development of disease modifying therapies. The rat alpha-synuclein (α-syn) preformed fibril (PFF) model induces synchro...

Full description

Saved in:
Bibliographic Details
Published inNPJ Parkinson's Disease Vol. 10; no. 1; pp. 7 - 17
Main Authors Patterson, Joseph R., Kochmanski, Joseph, Stoll, Anna C., Kubik, Michael, Kemp, Christopher J., Duffy, Megan F., Thompson, Kajene, Howe, Jacob W., Cole-Strauss, Allyson, Kuhn, Nathan C., Miller, Kathryn M., Nelson, Seth, Onyekpe, Christopher U., Beck, John S., Counts, Scott E., Bernstein, Alison I., Steece-Collier, Kathy, Luk, Kelvin C., Sortwell, Caryl E.
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 03.01.2024
Nature Publishing Group
Nature Portfolio
Subjects
631/378/1689/1718
631/378/548
Biomedical and Life Sciences
Biomedicine
Dopamine
Neurodegeneration
Neurology
Neurosciences
Online AccessGet full text

Cover

Abstract Examination of early phases of synucleinopathy when inclusions are present, but long before neurodegeneration occurs, is critical to both understanding disease progression and the development of disease modifying therapies. The rat alpha-synuclein (α-syn) preformed fibril (PFF) model induces synchronized synucleinopathy that recapitulates the pathological features of Parkinson’s disease (PD) and can be used to study synucleinopathy progression. In this model, phosphorylated α-syn (pSyn) inclusion-containing neurons and reactive microglia (major histocompatibility complex-II immunoreactive) peak in the substantia nigra pars compacta (SNpc) months before appreciable neurodegeneration. However, it remains unclear which specific genes are driving these phenotypic changes. To identify transcriptional changes associated with early synucleinopathy, we used laser capture microdissection of the SNpc paired with RNA sequencing (RNASeq). Precision collection of the SNpc allowed for the assessment of differential transcript expression in the nigral dopamine neurons and proximal glia. Transcripts upregulated in early synucleinopathy were mainly associated with an immune response, whereas transcripts downregulated were associated with neurotransmission and the dopamine pathway. A subset of 29 transcripts associated with neurotransmission/vesicular release and the dopamine pathway were verified in a separate cohort of males and females to confirm reproducibility. Within this subset, fluorescent in situ hybridization ( FISH ) was used to localize decreases in the Syt1 and Slc6a3 transcripts to pSyn inclusion-containing neurons. Identification of transcriptional changes in early synucleinopathy provides insight into the molecular mechanisms driving neurodegeneration.
AbstractList Examination of early phases of synucleinopathy when inclusions are present, but long before neurodegeneration occurs, is critical to both understanding disease progression and the development of disease modifying therapies. The rat alpha-synuclein (α-syn) preformed fibril (PFF) model induces synchronized synucleinopathy that recapitulates the pathological features of Parkinson’s disease (PD) and can be used to study synucleinopathy progression. In this model, phosphorylated α-syn (pSyn) inclusion-containing neurons and reactive microglia (major histocompatibility complex-II immunoreactive) peak in the substantia nigra pars compacta (SNpc) months before appreciable neurodegeneration. However, it remains unclear which specific genes are driving these phenotypic changes. To identify transcriptional changes associated with early synucleinopathy, we used laser capture microdissection of the SNpc paired with RNA sequencing (RNASeq). Precision collection of the SNpc allowed for the assessment of differential transcript expression in the nigral dopamine neurons and proximal glia. Transcripts upregulated in early synucleinopathy were mainly associated with an immune response, whereas transcripts downregulated were associated with neurotransmission and the dopamine pathway. A subset of 29 transcripts associated with neurotransmission/vesicular release and the dopamine pathway were verified in a separate cohort of males and females to confirm reproducibility. Within this subset, fluorescent in situ hybridization (FISH) was used to localize decreases in the Syt1 and Slc6a3 transcripts to pSyn inclusion-containing neurons. Identification of transcriptional changes in early synucleinopathy provides insight into the molecular mechanisms driving neurodegeneration.
Examination of early phases of synucleinopathy when inclusions are present, but long before neurodegeneration occurs, is critical to both understanding disease progression and the development of disease modifying therapies. The rat alpha-synuclein (α-syn) preformed fibril (PFF) model induces synchronized synucleinopathy that recapitulates the pathological features of Parkinson’s disease (PD) and can be used to study synucleinopathy progression. In this model, phosphorylated α-syn (pSyn) inclusion-containing neurons and reactive microglia (major histocompatibility complex-II immunoreactive) peak in the substantia nigra pars compacta (SNpc) months before appreciable neurodegeneration. However, it remains unclear which specific genes are driving these phenotypic changes. To identify transcriptional changes associated with early synucleinopathy, we used laser capture microdissection of the SNpc paired with RNA sequencing (RNASeq). Precision collection of the SNpc allowed for the assessment of differential transcript expression in the nigral dopamine neurons and proximal glia. Transcripts upregulated in early synucleinopathy were mainly associated with an immune response, whereas transcripts downregulated were associated with neurotransmission and the dopamine pathway. A subset of 29 transcripts associated with neurotransmission/vesicular release and the dopamine pathway were verified in a separate cohort of males and females to confirm reproducibility. Within this subset, fluorescent in situ hybridization ( FISH ) was used to localize decreases in the Syt1 and Slc6a3 transcripts to pSyn inclusion-containing neurons. Identification of transcriptional changes in early synucleinopathy provides insight into the molecular mechanisms driving neurodegeneration.
Examination of early phases of synucleinopathy when inclusions are present, but long before neurodegeneration occurs, is critical to both understanding disease progression and the development of disease modifying therapies. The rat alpha-synuclein (α-syn) preformed fibril (PFF) model induces synchronized synucleinopathy that recapitulates the pathological features of Parkinson's disease (PD) and can be used to study synucleinopathy progression. In this model, phosphorylated α-syn (pSyn) inclusion-containing neurons and reactive microglia (major histocompatibility complex-II immunoreactive) peak in the substantia nigra pars compacta (SNpc) months before appreciable neurodegeneration. However, it remains unclear which specific genes are driving these phenotypic changes. To identify transcriptional changes associated with early synucleinopathy, we used laser capture microdissection of the SNpc paired with RNA sequencing (RNASeq). Precision collection of the SNpc allowed for the assessment of differential transcript expression in the nigral dopamine neurons and proximal glia. Transcripts upregulated in early synucleinopathy were mainly associated with an immune response, whereas transcripts downregulated were associated with neurotransmission and the dopamine pathway. A subset of 29 transcripts associated with neurotransmission/vesicular release and the dopamine pathway were verified in a separate cohort of males and females to confirm reproducibility. Within this subset, fluorescent in situ hybridization (FISH) was used to localize decreases in the Syt1 and Slc6a3 transcripts to pSyn inclusion-containing neurons. Identification of transcriptional changes in early synucleinopathy provides insight into the molecular mechanisms driving neurodegeneration.Examination of early phases of synucleinopathy when inclusions are present, but long before neurodegeneration occurs, is critical to both understanding disease progression and the development of disease modifying therapies. The rat alpha-synuclein (α-syn) preformed fibril (PFF) model induces synchronized synucleinopathy that recapitulates the pathological features of Parkinson's disease (PD) and can be used to study synucleinopathy progression. In this model, phosphorylated α-syn (pSyn) inclusion-containing neurons and reactive microglia (major histocompatibility complex-II immunoreactive) peak in the substantia nigra pars compacta (SNpc) months before appreciable neurodegeneration. However, it remains unclear which specific genes are driving these phenotypic changes. To identify transcriptional changes associated with early synucleinopathy, we used laser capture microdissection of the SNpc paired with RNA sequencing (RNASeq). Precision collection of the SNpc allowed for the assessment of differential transcript expression in the nigral dopamine neurons and proximal glia. Transcripts upregulated in early synucleinopathy were mainly associated with an immune response, whereas transcripts downregulated were associated with neurotransmission and the dopamine pathway. A subset of 29 transcripts associated with neurotransmission/vesicular release and the dopamine pathway were verified in a separate cohort of males and females to confirm reproducibility. Within this subset, fluorescent in situ hybridization (FISH) was used to localize decreases in the Syt1 and Slc6a3 transcripts to pSyn inclusion-containing neurons. Identification of transcriptional changes in early synucleinopathy provides insight into the molecular mechanisms driving neurodegeneration.
Abstract Examination of early phases of synucleinopathy when inclusions are present, but long before neurodegeneration occurs, is critical to both understanding disease progression and the development of disease modifying therapies. The rat alpha-synuclein (α-syn) preformed fibril (PFF) model induces synchronized synucleinopathy that recapitulates the pathological features of Parkinson’s disease (PD) and can be used to study synucleinopathy progression. In this model, phosphorylated α-syn (pSyn) inclusion-containing neurons and reactive microglia (major histocompatibility complex-II immunoreactive) peak in the substantia nigra pars compacta (SNpc) months before appreciable neurodegeneration. However, it remains unclear which specific genes are driving these phenotypic changes. To identify transcriptional changes associated with early synucleinopathy, we used laser capture microdissection of the SNpc paired with RNA sequencing (RNASeq). Precision collection of the SNpc allowed for the assessment of differential transcript expression in the nigral dopamine neurons and proximal glia. Transcripts upregulated in early synucleinopathy were mainly associated with an immune response, whereas transcripts downregulated were associated with neurotransmission and the dopamine pathway. A subset of 29 transcripts associated with neurotransmission/vesicular release and the dopamine pathway were verified in a separate cohort of males and females to confirm reproducibility. Within this subset, fluorescent in situ hybridization (FISH) was used to localize decreases in the Syt1 and Slc6a3 transcripts to pSyn inclusion-containing neurons. Identification of transcriptional changes in early synucleinopathy provides insight into the molecular mechanisms driving neurodegeneration.
ArticleNumber 7
Author Patterson, Joseph R.
Kuhn, Nathan C.
Sortwell, Caryl E.
Miller, Kathryn M.
Kemp, Christopher J.
Duffy, Megan F.
Counts, Scott E.
Kochmanski, Joseph
Kubik, Michael
Bernstein, Alison I.
Nelson, Seth
Onyekpe, Christopher U.
Thompson, Kajene
Cole-Strauss, Allyson
Steece-Collier, Kathy
Howe, Jacob W.
Stoll, Anna C.
Beck, John S.
Luk, Kelvin C.
Author_xml – sequence: 1
  givenname: Joseph R.
  orcidid: 0000-0003-0926-7396
  surname: Patterson
  fullname: Patterson, Joseph R.
  email: patte401@msu.edu
  organization: Department of Translational Science and Molecular Medicine, Michigan State University, Neuroscience Program, Michigan State University
– sequence: 2
  givenname: Joseph
  orcidid: 0000-0002-8472-3032
  surname: Kochmanski
  fullname: Kochmanski, Joseph
  organization: Department of Translational Science and Molecular Medicine, Michigan State University
– sequence: 3
  givenname: Anna C.
  surname: Stoll
  fullname: Stoll, Anna C.
  organization: Department of Translational Science and Molecular Medicine, Michigan State University, Department of Pharmacology and Toxicology, Michigan State University
– sequence: 4
  givenname: Michael
  surname: Kubik
  fullname: Kubik, Michael
  organization: Department of Translational Science and Molecular Medicine, Michigan State University, Neuroscience Program, Michigan State University
– sequence: 5
  givenname: Christopher J.
  surname: Kemp
  fullname: Kemp, Christopher J.
  organization: Department of Translational Science and Molecular Medicine, Michigan State University
– sequence: 6
  givenname: Megan F.
  orcidid: 0000-0003-0094-0900
  surname: Duffy
  fullname: Duffy, Megan F.
  organization: Department of Translational Science and Molecular Medicine, Michigan State University, Neuroscience Program, Michigan State University
– sequence: 7
  givenname: Kajene
  surname: Thompson
  fullname: Thompson, Kajene
  organization: Department of Translational Science and Molecular Medicine, Michigan State University
– sequence: 8
  givenname: Jacob W.
  orcidid: 0000-0001-5510-1018
  surname: Howe
  fullname: Howe, Jacob W.
  organization: Department of Translational Science and Molecular Medicine, Michigan State University, Neuroscience Program, Michigan State University
– sequence: 9
  givenname: Allyson
  surname: Cole-Strauss
  fullname: Cole-Strauss, Allyson
  organization: Department of Translational Science and Molecular Medicine, Michigan State University
– sequence: 10
  givenname: Nathan C.
  surname: Kuhn
  fullname: Kuhn, Nathan C.
  organization: Department of Translational Science and Molecular Medicine, Michigan State University
– sequence: 11
  givenname: Kathryn M.
  surname: Miller
  fullname: Miller, Kathryn M.
  organization: Department of Translational Science and Molecular Medicine, Michigan State University, Neuroscience Program, Michigan State University
– sequence: 12
  givenname: Seth
  surname: Nelson
  fullname: Nelson, Seth
  organization: Department of Translational Science and Molecular Medicine, Michigan State University
– sequence: 13
  givenname: Christopher U.
  surname: Onyekpe
  fullname: Onyekpe, Christopher U.
  organization: Department of Translational Science and Molecular Medicine, Michigan State University
– sequence: 14
  givenname: John S.
  surname: Beck
  fullname: Beck, John S.
  organization: Department of Translational Science and Molecular Medicine, Michigan State University
– sequence: 15
  givenname: Scott E.
  surname: Counts
  fullname: Counts, Scott E.
  organization: Department of Translational Science and Molecular Medicine, Michigan State University, Neuroscience Program, Michigan State University
– sequence: 16
  givenname: Alison I.
  orcidid: 0000-0002-5589-4318
  surname: Bernstein
  fullname: Bernstein, Alison I.
  organization: Department of Translational Science and Molecular Medicine, Michigan State University, Department of Pharmacology and Toxicology, Rutgers University, Environmental and Occupational Health Science Institute, Rutgers University
– sequence: 17
  givenname: Kathy
  surname: Steece-Collier
  fullname: Steece-Collier, Kathy
  organization: Department of Translational Science and Molecular Medicine, Michigan State University
– sequence: 18
  givenname: Kelvin C.
  orcidid: 0000-0002-6591-6269
  surname: Luk
  fullname: Luk, Kelvin C.
  organization: Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine
– sequence: 19
  givenname: Caryl E.
  surname: Sortwell
  fullname: Sortwell, Caryl E.
  organization: Department of Translational Science and Molecular Medicine, Michigan State University, Neuroscience Program, Michigan State University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38172128$$D View this record in MEDLINE/PubMed
BookMark eNp9Uk1vFSEUJabG1to_4MJM4qabUb4GhpUxjdUmTdzUxB0BBt7jZR6MwGjm38vr1Np20bC4XDjncC_3vAZHIQYLwFsEPyBI-o-Zoo6gFmLSQsgwbJcX4AQTTtoedvzowf4YnOW8gxAiynrRwVfgmPSIY4T7E_DzJqmQTfJTiXtvmilF50cfNk10jVVpXJq8hNmM1oc4qbJdGh-apEqucZiNHZo_vmwrz7qY9jV1Xic_5jfgpVNjtmd38RT8uPxyc_Gtvf7-9eri83VrOopKqxw3xnKOsNKcus6xuggVyBGhlWId1pgIxg1TbNC0xwpj1BNLBiJ6zTQ5BVer7hDVTk7J71VaZFRe3h7EtJEqFV8bkL0eLIWIMcQtHazWUHQEO-wMVdgYWLU-rVrTrGsrxoaS1PhI9PFN8Fu5ib8lgpxR0aGqcH6nkOKv2eYi9z4bO44q2DhniQWCSBBKSIW-fwLdxTmF-lcVBQXpKKQH1LuHJd3X8m-CFYBXgEkx5zqFewiC8uAUuTpFVqfIW6fIpZL6JyTjiyo-Htry4_NUslJzfSdsbPpf9jOsv14H1Eo
CitedBy_id crossref_primary_10_1111_ejn_16275
crossref_primary_10_1002_jbt_70207
crossref_primary_10_1016_j_nbd_2024_106411
crossref_primary_10_1016_j_bbrc_2025_151419
Cites_doi 10.1111/j.1471-4159.1985.tb10550.x
10.1007/s00401-006-0096-2
10.1016/j.neuroscience.2009.08.017
10.1016/j.nbd.2003.09.001
10.1073/pnas.1112690108
10.1007/s10571-007-9227-0
10.1038/nprot.2014.143
10.1523/JNEUROSCI.1091-10.2010
10.1016/j.neuron.2009.12.023
10.1038/nn.4529
10.1016/j.nbd.2022.105804
10.1016/j.cell.2018.07.028
10.1007/978-1-61779-163-5_30
10.1016/j.nbd.2017.05.014
10.1016/S0006-8993(03)03354-7
10.1186/1756-6606-4-43
10.1016/j.neuron.2011.08.033
10.1002/1531-8249(200004)47:4<493::AID-ANA13>3.0.CO;2-4
10.1186/s12974-018-1171-z
10.1186/s40478-017-0494-9
10.1126/science.287.5456.1265
10.1016/j.nbd.2019.104525
10.1523/JNEUROSCI.22-07-02780.2002
10.1093/nar/gkaa638
10.3389/fphys.2019.01081
10.1007/s00401-011-0815-1
10.1586/14737175.2014.960399
10.1002/jnr.22611
10.1371/journal.pone.0128651
10.1016/j.nicl.2017.03.011
10.1089/omi.2011.0118
10.1001/archneur.63.4.584
10.1046/j.1471-4159.2003.01742.x
10.1212/WNL.55.9.1358
10.1523/JNEUROSCI.3040-07.2008
10.1523/JNEUROSCI.22-08-03090.2002
10.1016/S0896-6273(03)00568-3
10.3390/biom12020179
10.1212/WNL.0000000000004764
10.1007/s00401-007-0303-9
10.1007/s00702-004-0212-1
10.1038/s41531-021-00161-2
10.1242/jcs.02481
10.1042/bj2750427
10.1038/nature21029
10.1126/science.1227157
10.1073/pnas.1309143110
10.1038/s41531-022-00322-x
10.1523/JNEUROSCI.5427-08.2009
10.1016/j.expneurol.2005.04.011
10.1016/j.jalz.2016.04.005
10.1172/JCI72176
10.1016/j.celrep.2017.09.039
10.1016/S1353-8020(08)70009-9
10.3390/cells10030658
10.1074/jbc.M111.249532
10.1001/archneur.62.6.917
10.1016/j.nbd.2020.105229
10.1016/j.neuroscience.2014.01.025
10.1016/j.celrep.2015.01.060
10.1093/brain/114.5.2283
10.1098/rstb.1999.0378
10.3233/JPD-171248
10.1016/j.parkreldis.2021.06.010
10.1007/978-94-017-7215-0_9
10.1002/ana.21995
10.1073/pnas.1505953112
10.3389/fnmol.2018.00213
10.1016/S0022-510X(97)00100-7
10.1016/j.ymthe.2017.04.018
10.1186/1477-5956-6-8
10.1038/s41531-021-00179-6
10.1016/j.nbd.2011.08.033
10.1074/jbc.M115.686584
10.1016/j.nbd.2015.06.003
10.1523/JNEUROSCI.4564-06.2007
10.1016/j.neuron.2013.10.022
10.1111/j.1468-1331.2010.03246.x
10.1038/nmeth.4197
10.1186/s12974-020-01776-7
10.1016/j.neuro.2011.03.013
10.1146/annurev.neuro.20.1.125
10.1186/1742-2094-2-14
10.1007/s10048-006-0033-5
10.1093/brain/awt192
10.3233/JPD-191683
10.1002/ana.20226
10.1073/pnas.1200575109
10.1093/brain/awx352
10.1002/ana.24571
10.1016/j.cell.2016.09.027
10.1186/1742-2094-3-29
10.1038/nmeth.4324
10.1073/pnas.1617259114
10.1038/srep40699
10.1074/jbc.M116.734707
10.1371/journal.pcbi.1009364
10.1038/nmeth.2089
10.1523/JNEUROSCI.1952-20.2020
10.1016/j.neulet.2014.03.016
10.1016/j.jesp.2013.03.013
10.1016/j.aninu.2016.02.005
10.1016/0140-6736(90)91006-V
10.1016/j.nbd.2007.02.009
10.1002/glia.24149
10.1016/j.neures.2020.11.004
10.1186/s12974-019-1636-8
10.1073/pnas.0912934107
10.1007/978-1-4939-7558-7_19
10.1111/j.1471-4159.2006.04146.x
10.1073/pnas.1525591113
10.1136/jnnp.54.1.30
10.1212/01.wnl.0000335973.66333.58
10.1016/j.celrep.2014.10.008
10.1016/j.nbd.2015.10.021
10.1111/j.1471-4159.2012.07924.x
10.1073/pnas.1913904117
10.1016/j.tins.2020.01.004
10.1016/j.nbd.2005.08.005
10.3390/biomedicines10071593
10.1371/journal.pone.0011464
10.1002/mds.29051
10.3791/4389
10.3791/59758
ContentType Journal Article
Copyright The Author(s) 2024
2024. The Author(s).
The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2024
– notice: 2024. The Author(s).
– notice: The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
NPM
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
7X8
5PM
DOA
DOI 10.1038/s41531-023-00620-y
DatabaseName Springer Nature OA Free Journals
CrossRef
PubMed
ProQuest Central (Corporate)
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database

PubMed
MEDLINE - Academic

CrossRef
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: 7X7
  name: Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2373-8057
EndPage 17
ExternalDocumentID oai_doaj_org_article_8bde4016617e4debb09532f2fc4a2cc0
PMC10764951
38172128
10_1038_s41531_023_00620_y
Genre Journal Article
GrantInformation_xml – fundername: U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS)
– fundername: United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs (CDMRP)
  grantid: GRANT12471958
  funderid: https://doi.org/10.13039/100000090
– fundername: U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS)
  grantid: NS111333; NS099416
  funderid: https://doi.org/10.13039/100000065
– fundername: United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs (CDMRP)
  grantid: GRANT12471958
– fundername: U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS)
  grantid: NS111333
– fundername: U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS)
  grantid: NS099416
GroupedDBID 0R~
3V.
53G
5VS
7X7
8FI
8FJ
AAJSJ
ABUWG
ACGFS
ACSMW
ADBBV
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BCNDV
BENPR
BPHCQ
BVXVI
C6C
CCPQU
EBLON
EBS
EMOBN
FYUFA
GROUPED_DOAJ
HMCUK
HYE
M~E
NAO
NO~
OK1
PGMZT
PIMPY
PQQKQ
PROAC
RNT
RPM
SNYQT
UKHRP
AASML
AAYXX
CITATION
PHGZM
PHGZT
NPM
7XB
8FK
AARCD
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQUKI
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c541t-af7cce7712ab74f5f6f6f3491f39baa652b23967c6a6db482a22183e3d398b6b3
IEDL.DBID 7X7
ISSN 2373-8057
IngestDate Wed Aug 27 01:22:18 EDT 2025
Thu Aug 21 18:42:32 EDT 2025
Fri Jul 11 16:17:15 EDT 2025
Wed Aug 13 10:54:30 EDT 2025
Thu Apr 03 07:08:01 EDT 2025
Tue Jul 01 01:42:11 EDT 2025
Thu Apr 24 23:04:16 EDT 2025
Fri Feb 21 02:40:29 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License 2024. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c541t-af7cce7712ab74f5f6f6f3491f39baa652b23967c6a6db482a22183e3d398b6b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-6591-6269
0000-0003-0094-0900
0000-0003-0926-7396
0000-0002-8472-3032
0000-0001-5510-1018
0000-0002-5589-4318
OpenAccessLink https://www.proquest.com/docview/2909354043?pq-origsite=%requestingapplication%
PMID 38172128
PQID 2909354043
PQPubID 2041921
PageCount 17
ParticipantIDs doaj_primary_oai_doaj_org_article_8bde4016617e4debb09532f2fc4a2cc0
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10764951
proquest_miscellaneous_2910193433
proquest_journals_2909354043
pubmed_primary_38172128
crossref_primary_10_1038_s41531_023_00620_y
crossref_citationtrail_10_1038_s41531_023_00620_y
springer_journals_10_1038_s41531_023_00620_y
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-01-03
PublicationDateYYYYMMDD 2024-01-03
PublicationDate_xml – month: 01
  year: 2024
  text: 2024-01-03
  day: 03
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: United States
PublicationTitle NPJ Parkinson's Disease
PublicationTitleAbbrev npj Parkinsons Dis
PublicationTitleAlternate NPJ Parkinsons Dis
PublicationYear 2024
Publisher Nature Publishing Group UK
Nature Publishing Group
Nature Portfolio
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
– name: Nature Portfolio
References Follmer (CR89) 2015; 290
Loeffler, Camp, Conant (CR102) 2006; 3
Polinski (CR113) 2018; 8
Bu, Farrer, Khoshbouei (CR74) 2021; 7
Südhof (CR51) 2013; 80
Izco, Blesa, Verona, Cooper, Alvarez-Erviti (CR37) 2021; 170
Grünewald (CR19) 2016; 79
Nemani (CR55) 2010; 65
Lohr, Miller (CR70) 2014; 14
Kordower (CR82) 2013; 136
Liu, Edwards (CR69) 1997; 20
Tehranian, Montoya, Van Laar, Hastings, Perez (CR67) 2006; 99
Thomsen (CR104) 2021; 149
Stoll, Sortwell (CR105) 2022; 171
Baptista (CR62) 2003; 85
Tarutani (CR116) 2016; 291
Hilfiker (CR46) 1999; 354
Mochida (CR49) 2022; 10
Ford (CR71) 2014; 282
Abdelmotilib (CR117) 2017; 105
Witkovsky, Patel, Lee, Rice (CR61) 2009; 164
Lundblad, Decressac, Mattsson, Björklund (CR78) 2012; 109
Singleton (CR100) 2003; 302
Saunders (CR42) 2018; 174
Osterberg (CR26) 2015; 10
Mandel, Fishman, Youdim (CR97) 2007; 13
Volpicelli-Daley, Luk, Lee (CR115) 2014; 9
Plotegher (CR95) 2017; 7
Goldstein (CR99) 2011; 18
Botta-Orfila (CR11) 2012; 45
Lee (CR2) 2000; 47
Peng, Tehranian, Dietrich, Stefanis, Perez (CR65) 2005; 118
Kramer, Schulz-Schaeffer (CR57) 2007; 27
Dettmer, Newman, von Saucken, Bartels, Selkoe (CR88) 2015; 112
Duda, Fauler, Gründemann, Liss (CR14) 2018; 1723
Poulin (CR40) 2014; 9
Nandhagopal (CR4) 2008; 71
Su (CR23) 2017; 25
Galter, Buervenich, Carmine, Anvret, Olson (CR96) 2003; 14
Mathys (CR106) 2017; 21
Chung, Koprich, Siddiqi, Isacson (CR58) 2009; 29
Patterson (CR28) 2019; 130
Kurz (CR76) 2010; 5
Pakkenberg, Møller, Gundersen, Mouritzen Dam, Pakkenberg (CR10) 1991; 54
Liu (CR44) 2019; 10
Jinsmaa (CR93) 2014; 569
Grünblatt (CR17) 2004; 111
CR68
Poulin, Gaertner, Moreno-Ramos, Awatramani (CR41) 2020; 43
Dauer, Przedborski (CR1) 2003; 39
Liu (CR43) 2014; 124
Isgrò, Bottoni, Scatena (CR110) 2015; 867
Anderson, Mariappan, Buettner, Doorn (CR86) 2011; 286
Elstner (CR16) 2011; 4
Liddelow (CR101) 2017; 541
Scott (CR53) 2010; 30
Paumier (CR25) 2015; 82
Miller, Mercado, Sortwell (CR22) 2021; 7
Galvin (CR90) 2006; 112
Leys, Ley, Klein, Bernard, Licata (CR125) 2013; 49
Denker, Krohnert, Buckers, Neher, Rizzoli (CR45) 2011; 108
Ross (CR8) 2004; 56
Zhang, Augustine (CR47) 2021; 10
Duffy (CR27) 2018; 15
Dahodwala (CR109) 2018; 90
Garcia (CR36) 2022; 70
Cheng, Ulane, Burke (CR9) 2010; 67
Logan, Bendor, Toupin, Thorn, Edwards (CR94) 2017; 20
CR114
CR119
Schneider, Rasband, Eliceiri (CR118) 2012; 9
Burke, Li, Williams, Nonneman, Zahm (CR83) 2003; 989
Ji (CR121) 2020; 48
Greffard (CR6) 2006; 63
Peshavaria, Day (CR112) 1991; 275
Miller (CR30) 2021; 41
Luk (CR24) 2012; 338
Lambert (CR72) 2010; 107
Cerri, Mus, Blandini (CR108) 2019; 9
Croisier, Moran, Dexter, Pearce, Graeber (CR33) 2005; 2
Caminiti (CR81) 2017; 14
Lam (CR77) 2011; 89
Guo (CR75) 2008; 28
Masliah (CR64) 2000; 287
Urakubo, Yagishita, Kasai, Kubota, Ishii (CR73) 2021; 17
Fearnley, Lees (CR5) 1991; 114
Howe (CR29) 2021; 89
Mahul-Mellier (CR31) 2020; 117
Yu, Wang, Han, He (CR123) 2012; 16
Patro, Duggal, Love, Irizarry, Kingsford (CR120) 2017; 14
Marsden (CR3) 1990; 335
Duke (CR15) 2006; 7
Unger (CR80) 2006; 21
Ji (CR111) 2016; 2
La Manno (CR39) 2016; 167
Perez (CR66) 2002; 22
Werner, Heyny-von Haussen, Mall, Wolf (CR98) 2008; 6
Volpicelli-Daley (CR38) 2011; 72
He (CR48) 2018; 11
Kouroupi (CR56) 2017; 114
Dijkstra (CR13) 2015; 10
Zhou (CR32) 2011; 121
Kirik (CR63) 2002; 22
Rodrigues (CR50) 2016; 113
Takikawa, Nishimune (CR52) 2022; 12
Burke (CR87) 2008; 115
Janezic (CR92) 2013; 110
Harms (CR103) 2017; 5
Ma, Röyttä, Rinne, Collan, Rinne (CR7) 1997; 151
Earls (CR35) 2019; 16
Nuber (CR79) 2008; 28
Lu (CR21) 2005; 195
Maring, Deitrich, Little (CR84) 1985; 45
Bereczki (CR60) 2016; 12
Patterson (CR124) 2022; 8
Goldstein (CR91) 2012; 123
Mexas, Florang, Doorn (CR85) 2011; 32
Hauser (CR20) 2005; 62
Baldereschi (CR107) 2000; 55
Pimentel, Bray, Puente, Melsted, Pachter (CR122) 2017; 14
Rostami (CR34) 2020; 17
Bereczki (CR59) 2018; 141
Cantuti-Castelvetri (CR12) 2007; 26
Gründemann, Schlaudraff, Liss (CR18) 2011; 755
Kohl (CR54) 2016; 85
D Kirik (620_CR63) 2002; 22
SA Mandel (620_CR97) 2007; 13
J-F Poulin (620_CR41) 2020; 43
KM Lohr (620_CR70) 2014; 14
AS Harms (620_CR103) 2017; 5
H Ji (620_CR111) 2016; 2
LA Volpicelli-Daley (620_CR38) 2011; 72
S Rodrigues (620_CR50) 2016; 113
KM Miller (620_CR22) 2021; 7
S Greffard (620_CR6) 2006; 63
B Pakkenberg (620_CR10) 1991; 54
J Duda (620_CR14) 2018; 1723
P Garcia (620_CR36) 2022; 70
NA Lambert (620_CR72) 2010; 107
DS Goldstein (620_CR99) 2011; 18
S Nuber (620_CR79) 2008; 28
Y Liu (620_CR44) 2019; 10
EL Unger (620_CR80) 2006; 21
JR Patterson (620_CR28) 2019; 130
L Lu (620_CR21) 2005; 195
M Elstner (620_CR16) 2011; 4
MF Duffy (620_CR27) 2018; 15
JH Kordower (620_CR82) 2013; 136
I Cantuti-Castelvetri (620_CR12) 2007; 26
HA Lam (620_CR77) 2011; 89
WJ Burke (620_CR83) 2003; 989
H Urakubo (620_CR73) 2021; 17
DG Anderson (620_CR86) 2011; 286
MB Thomsen (620_CR104) 2021; 149
AC Stoll (620_CR105) 2022; 171
VR Osterberg (620_CR26) 2015; 10
J-F Poulin (620_CR40) 2014; 9
CP Ford (620_CR71) 2014; 282
X Su (620_CR23) 2017; 25
T Botta-Orfila (620_CR11) 2012; 45
KC Luk (620_CR24) 2012; 338
DA Scott (620_CR53) 2010; 30
E Masliah (620_CR64) 2000; 287
H Mathys (620_CR106) 2017; 21
JT Guo (620_CR75) 2008; 28
J Gründemann (620_CR18) 2011; 755
WJ Burke (620_CR87) 2008; 115
S Mochida (620_CR49) 2022; 10
G Liu (620_CR43) 2014; 124
A Tarutani (620_CR116) 2016; 291
R He (620_CR48) 2018; 11
RG Perez (620_CR66) 2002; 22
CJ Werner (620_CR98) 2008; 6
MA Isgrò (620_CR110) 2015; 867
U Dettmer (620_CR88) 2015; 112
H Abdelmotilib (620_CR117) 2017; 105
X Peng (620_CR65) 2005; 118
C Leys (620_CR125) 2013; 49
CS Lee (620_CR2) 2000; 47
E Bereczki (620_CR59) 2018; 141
620_CR68
J Rostami (620_CR34) 2020; 17
MJ Baptista (620_CR62) 2003; 85
Y Liu (620_CR69) 1997; 20
CD Marsden (620_CR3) 1990; 335
VM Nemani (620_CR55) 2010; 65
M Lundblad (620_CR78) 2012; 109
JE Galvin (620_CR90) 2006; 112
S Cerri (620_CR108) 2019; 9
JW Howe (620_CR29) 2021; 89
A Kurz (620_CR76) 2010; 5
Y Jinsmaa (620_CR93) 2014; 569
R Patro (620_CR120) 2017; 14
J Zhou (620_CR32) 2011; 121
TC Südhof (620_CR51) 2013; 80
AA Dijkstra (620_CR13) 2015; 10
R Tehranian (620_CR67) 2006; 99
N Dahodwala (620_CR109) 2018; 90
W Dauer (620_CR1) 2003; 39
M Izco (620_CR37) 2021; 170
M Zhang (620_CR47) 2021; 10
A Saunders (620_CR42) 2018; 174
M Bu (620_CR74) 2021; 7
A Grünewald (620_CR19) 2016; 79
E Croisier (620_CR33) 2005; 2
ML Kramer (620_CR57) 2007; 27
RH Earls (620_CR35) 2019; 16
NK Polinski (620_CR113) 2018; 8
SP Caminiti (620_CR81) 2017; 14
GW Ross (620_CR8) 2004; 56
SA Liddelow (620_CR101) 2017; 541
E Grünblatt (620_CR17) 2004; 111
J-A Maring (620_CR84) 1985; 45
S Janezic (620_CR92) 2013; 110
AB Singleton (620_CR100) 2003; 302
T Logan (620_CR94) 2017; 20
H-C Cheng (620_CR9) 2010; 67
A Denker (620_CR45) 2011; 108
Z Kohl (620_CR54) 2016; 85
N Plotegher (620_CR95) 2017; 7
620_CR119
620_CR114
LA Volpicelli-Daley (620_CR115) 2014; 9
KM Miller (620_CR30) 2021; 41
LM Mexas (620_CR85) 2011; 32
DS Goldstein (620_CR91) 2012; 123
DA Loeffler (620_CR102) 2006; 3
CY Chung (620_CR58) 2009; 29
M Baldereschi (620_CR107) 2000; 55
E Bereczki (620_CR60) 2016; 12
G Yu (620_CR123) 2012; 16
CA Schneider (620_CR118) 2012; 9
H Pimentel (620_CR122) 2017; 14
C Follmer (620_CR89) 2015; 290
JR Patterson (620_CR124) 2022; 8
DC Duke (620_CR15) 2006; 7
G Kouroupi (620_CR56) 2017; 114
D Galter (620_CR96) 2003; 14
KL Paumier (620_CR25) 2015; 82
P Witkovsky (620_CR61) 2009; 164
SY Ma (620_CR7) 1997; 151
A-L Mahul-Mellier (620_CR31) 2020; 117
S Hilfiker (620_CR46) 1999; 354
G La Manno (620_CR39) 2016; 167
JM Fearnley (620_CR5) 1991; 114
X Ji (620_CR121) 2020; 48
R Nandhagopal (620_CR4) 2008; 71
M Peshavaria (620_CR112) 1991; 275
MA Hauser (620_CR20) 2005; 62
K Takikawa (620_CR52) 2022; 12
References_xml – volume: 45
  start-page: 1903
  year: 1985
  end-page: 1910
  ident: CR84
  article-title: Partial purification and properties of human brain Aldehyde Dehydrogenases
  publication-title: J. Neurochem
  doi: 10.1111/j.1471-4159.1985.tb10550.x
– volume: 112
  start-page: 115
  year: 2006
  end-page: 126
  ident: CR90
  article-title: Interaction of alpha-synuclein and dopamine metabolites in the pathogenesis of Parkinson’s disease: a case for the selective vulnerability of the substantia nigra
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-006-0096-2
– ident: CR68
– volume: 164
  start-page: 488
  year: 2009
  end-page: 496
  ident: CR61
  article-title: Immunocytochemical identification of proteins involved in dopamine release from the somatodendritic compartment of nigral dopaminergic neurons
  publication-title: Neuroscience
  doi: 10.1016/j.neuroscience.2009.08.017
– volume: 14
  start-page: 637
  year: 2003
  end-page: 647
  ident: CR96
  article-title: ALDH1 mRNA: presence in human dopamine neurons and decreases in substantia nigra in Parkinson’s disease and in the ventral tegmental area in schizophrenia
  publication-title: Neurobiol. Dis.
  doi: 10.1016/j.nbd.2003.09.001
– volume: 108
  start-page: 17183
  year: 2011
  end-page: 17188
  ident: CR45
  article-title: The reserve pool of synaptic vesicles acts as a buffer for proteins involved in synaptic vesicle recycling
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.1112690108
– volume: 28
  start-page: 35
  year: 2008
  end-page: 47
  ident: CR75
  article-title: Inhibition of Vesicular Monoamine Transporter-2 activity in α-Synuclein stably transfected SH-SY5Y cells
  publication-title: Cell Mol. Neurobiol.
  doi: 10.1007/s10571-007-9227-0
– volume: 9
  start-page: 2135
  year: 2014
  end-page: 2146
  ident: CR115
  article-title: Addition of exogenous alpha-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous alpha-synuclein to Lewy body and Lewy neurite-like aggregates
  publication-title: Nat. Protoc.
  doi: 10.1038/nprot.2014.143
– volume: 30
  start-page: 8083
  year: 2010
  end-page: 8095
  ident: CR53
  article-title: A pathologic cascade leading to synaptic dysfunction in -Synuclein-induced neurodegeneration
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.1091-10.2010
– volume: 65
  start-page: 66
  year: 2010
  end-page: 79
  ident: CR55
  article-title: Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis
  publication-title: Neuron
  doi: 10.1016/j.neuron.2009.12.023
– volume: 20
  start-page: 681
  year: 2017
  end-page: 689
  ident: CR94
  article-title: α-Synuclein promotes dilation of the exocytotic fusion pore
  publication-title: Nat. Neurosci.
  doi: 10.1038/nn.4529
– volume: 171
  start-page: 105804
  year: 2022
  ident: CR105
  article-title: Leveraging the preformed fibril model to distinguish between alpha-synuclein inclusion- and nigrostriatal degeneration-associated immunogenicity
  publication-title: Neurobiol. Dis.
  doi: 10.1016/j.nbd.2022.105804
– volume: 174
  start-page: 1015
  year: 2018
  end-page: 1030.e16
  ident: CR42
  article-title: Molecular diversity and specializations among the cells of the adult mouse brain
  publication-title: Cell
  doi: 10.1016/j.cell.2018.07.028
– volume: 755
  start-page: 363
  year: 2011
  end-page: 374
  ident: CR18
  article-title: UV-laser microdissection and mRNA expression analysis of individual neurons from postmortem Parkinson’s disease brains
  publication-title: Methods Mol. Biol.
  doi: 10.1007/978-1-61779-163-5_30
– volume: 105
  start-page: 84
  year: 2017
  end-page: 98
  ident: CR117
  article-title: alpha-Synuclein fibril-induced inclusion spread in rats and mice correlates with dopaminergic Neurodegeneration
  publication-title: Neurobiol. Dis.
  doi: 10.1016/j.nbd.2017.05.014
– volume: 989
  start-page: 205
  year: 2003
  end-page: 213
  ident: CR83
  article-title: 3,4-Dihydroxyphenylacetaldehyde is the toxic dopamine metabolite in vivo: implications for Parkinson’s disease pathogenesis
  publication-title: Brain Res
  doi: 10.1016/S0006-8993(03)03354-7
– volume: 4
  year: 2011
  ident: CR16
  article-title: Neuromelanin, neurotransmitter status and brainstem location determine the differential vulnerability of catecholaminergic neurons to mitochondrial DNA deletions
  publication-title: Mol. Brain
  doi: 10.1186/1756-6606-4-43
– volume: 72
  start-page: 57
  year: 2011
  end-page: 71
  ident: CR38
  article-title: Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death
  publication-title: Neuron
  doi: 10.1016/j.neuron.2011.08.033
– volume: 47
  start-page: 493
  year: 2000
  end-page: 503
  ident: CR2
  article-title: In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson’s disease
  publication-title: Ann. Neurol.
  doi: 10.1002/1531-8249(200004)47:4<493::AID-ANA13>3.0.CO;2-4
– volume: 15
  year: 2018
  ident: CR27
  article-title: Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration
  publication-title: J. Neuroinflammation
  doi: 10.1186/s12974-018-1171-z
– volume: 5
  start-page: 85
  year: 2017
  ident: CR103
  article-title: α-Synuclein fibrils recruit peripheral immune cells in the rat brain prior to neurodegeneration
  publication-title: Acta Neuropathol. Commun.
  doi: 10.1186/s40478-017-0494-9
– volume: 287
  start-page: 1265
  year: 2000
  end-page: 1269
  ident: CR64
  article-title: Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders
  publication-title: Science
  doi: 10.1126/science.287.5456.1265
– volume: 130
  start-page: 104525
  year: 2019
  ident: CR28
  article-title: Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrils
  publication-title: Neurobiol. Dis.
  doi: 10.1016/j.nbd.2019.104525
– volume: 22
  start-page: 2780
  year: 2002
  end-page: 2791
  ident: CR63
  article-title: Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.22-07-02780.2002
– volume: 48
  start-page: 8320
  year: 2020
  end-page: 8331
  ident: CR121
  article-title: A comprehensive rat transcriptome built from large scale RNA-seq-based annotation
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkaa638
– volume: 10
  start-page: 1081
  year: 2019
  ident: CR44
  article-title: Identification of hub genes and key pathways associated with bipolar disorder based on weighted gene co-expression network analysis
  publication-title: Front Physiol.
  doi: 10.3389/fphys.2019.01081
– volume: 121
  start-page: 695
  year: 2011
  end-page: 704
  ident: CR32
  article-title: Changes in the solubility and phosphorylation of α-synuclein over the course of Parkinson’s disease
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-011-0815-1
– volume: 14
  start-page: 1115
  year: 2014
  end-page: 1117
  ident: CR70
  article-title: VMAT2 and Parkinson’s disease: harnessing the dopamine vesicle
  publication-title: Expert Rev. Neurother.
  doi: 10.1586/14737175.2014.960399
– volume: 89
  start-page: 1091
  year: 2011
  end-page: 1102
  ident: CR77
  article-title: Elevated tonic extracellular dopamine concentration and altered dopamine modulation of synaptic activity precede dopamine loss in the striatum of mice overexpressing human α-synuclein
  publication-title: J. Neurosci. Res
  doi: 10.1002/jnr.22611
– volume: 10
  start-page: e0128651
  year: 2015
  ident: CR13
  article-title: Evidence for immune response, axonal dysfunction and reduced endocytosis in the Substantia Nigra in Early Stage Parkinson’s Disease
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0128651
– volume: 14
  start-page: 734
  year: 2017
  end-page: 740
  ident: CR81
  article-title: Axonal damage and loss of connectivity in nigrostriatal and mesolimbic dopamine pathways in early Parkinson’s disease
  publication-title: Neuroimage Clin.
  doi: 10.1016/j.nicl.2017.03.011
– volume: 16
  start-page: 284
  year: 2012
  end-page: 287
  ident: CR123
  article-title: clusterProfiler: an R package for comparing biological themes among gene clusters
  publication-title: OMICS
  doi: 10.1089/omi.2011.0118
– volume: 63
  start-page: 584
  year: 2006
  end-page: 588
  ident: CR6
  article-title: Motor score of the Unified Parkinson Disease Rating Scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra
  publication-title: Arch. Neurol.
  doi: 10.1001/archneur.63.4.584
– volume: 85
  start-page: 957
  year: 2003
  end-page: 968
  ident: CR62
  article-title: Co-ordinate transcriptional regulation of dopamine synthesis genes by alpha-synuclein in human neuroblastoma cell lines
  publication-title: J. Neurochem
  doi: 10.1046/j.1471-4159.2003.01742.x
– volume: 302
  start-page: 841
  year: 2003
  ident: CR100
  article-title: alpha-Synuclein locus triplication causes Parkinson’s disease
  publication-title: Science (1979)
– volume: 55
  start-page: 1358
  year: 2000
  end-page: 1363
  ident: CR107
  article-title: Parkinson’s disease and parkinsonism in a longitudinal study: Two-fold higher incidence in men
  publication-title: Neurology
  doi: 10.1212/WNL.55.9.1358
– volume: 28
  start-page: 2471
  year: 2008
  end-page: 2484
  ident: CR79
  article-title: Neurodegeneration and motor dysfunction in a conditional model of Parkinson’s disease
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.3040-07.2008
– volume: 22
  start-page: 3090
  year: 2002
  end-page: 3099
  ident: CR66
  article-title: A role for alpha-synuclein in the regulation of dopamine biosynthesis
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.22-08-03090.2002
– volume: 39
  start-page: 889
  year: 2003
  end-page: 909
  ident: CR1
  article-title: Parkinson’s disease: mechanisms and models
  publication-title: Neuron
  doi: 10.1016/S0896-6273(03)00568-3
– volume: 12
  start-page: 179
  year: 2022
  ident: CR52
  article-title: Similarity and diversity of presynaptic molecules at neuromuscular junctions and central synapses
  publication-title: Biomolecules
  doi: 10.3390/biom12020179
– volume: 90
  start-page: e48
  year: 2018
  end-page: e54
  ident: CR109
  article-title: Sex disparities in access to caregiving in Parkinson’s disease
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000004764
– volume: 115
  start-page: 193
  year: 2008
  end-page: 203
  ident: CR87
  article-title: Aggregation of α-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-007-0303-9
– volume: 111
  start-page: 1543
  year: 2004
  end-page: 1573
  ident: CR17
  article-title: Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes
  publication-title: J. Neural Transm.
  doi: 10.1007/s00702-004-0212-1
– volume: 7
  start-page: 22
  year: 2021
  ident: CR74
  article-title: Dynamic control of the dopamine transporter in neurotransmission and homeostasis
  publication-title: NPJ Parkinsons Dis.
  doi: 10.1038/s41531-021-00161-2
– volume: 118
  start-page: 3523
  year: 2005
  end-page: 3530
  ident: CR65
  article-title: Alpha-synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells
  publication-title: J. Cell Sci.
  doi: 10.1242/jcs.02481
– volume: 275
  start-page: 427
  year: 1991
  end-page: 433
  ident: CR112
  article-title: Molecular structure of the human muscle-specific enolase gene ( )
  publication-title: Biochem. J.
  doi: 10.1042/bj2750427
– volume: 541
  start-page: 481
  year: 2017
  end-page: 487
  ident: CR101
  article-title: Neurotoxic reactive astrocytes are induced by activated microglia
  publication-title: Nature
  doi: 10.1038/nature21029
– volume: 338
  start-page: 949
  year: 2012
  end-page: 953
  ident: CR24
  article-title: Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice
  publication-title: Science
  doi: 10.1126/science.1227157
– ident: CR114
– volume: 110
  start-page: E4016
  year: 2013
  end-page: 25
  ident: CR92
  article-title: Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model
  publication-title: Proc. Natl Acad. Sci.
  doi: 10.1073/pnas.1309143110
– volume: 8
  start-page: 61
  year: 2022
  ident: CR124
  article-title: Beta2-adrenoreceptor agonist clenbuterol produces transient decreases in alpha-synuclein mRNA but no long-term reduction in protein
  publication-title: NPJ Parkinsons Dis.
  doi: 10.1038/s41531-022-00322-x
– volume: 29
  start-page: 3365
  year: 2009
  end-page: 3373
  ident: CR58
  article-title: Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede Dopaminergic neuronal loss in a rat model of AAV α-Synucleinopathy
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.5427-08.2009
– volume: 195
  start-page: 27
  year: 2005
  end-page: 39
  ident: CR21
  article-title: Gene expression profiling of Lewy body-bearing neurons in Parkinson’s disease
  publication-title: Exp. Neurol.
  doi: 10.1016/j.expneurol.2005.04.011
– volume: 12
  start-page: 1149
  year: 2016
  end-page: 1158
  ident: CR60
  article-title: Synaptic proteins predict cognitive decline in Alzheimer’s disease and Lewy body dementia
  publication-title: Alzheimer’s Dement.
  doi: 10.1016/j.jalz.2016.04.005
– volume: 124
  start-page: 3032
  year: 2014
  end-page: 3046
  ident: CR43
  article-title: Aldehyde dehydrogenase 1 defines and protects a nigrostriatal dopaminergic neuron subpopulation
  publication-title: J. Clin. Invest
  doi: 10.1172/JCI72176
– volume: 21
  start-page: 366
  year: 2017
  end-page: 380
  ident: CR106
  article-title: Temporal tracking of Microglia activation in neurodegeneration at single-cell resolution
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2017.09.039
– volume: 13
  start-page: S242
  year: 2007
  end-page: S247
  ident: CR97
  article-title: Gene and protein signatures in sporadic Parkinson’s disease and a novel genetic model of PD
  publication-title: Parkinsonism Relat. Disord.
  doi: 10.1016/S1353-8020(08)70009-9
– volume: 10
  start-page: 658
  year: 2021
  ident: CR47
  article-title: Synapsins and the synaptic vesicle reserve pool: floats or anchors?
  publication-title: Cells
  doi: 10.3390/cells10030658
– volume: 286
  start-page: 26978
  year: 2011
  end-page: 26986
  ident: CR86
  article-title: Oxidation of 3,4-Dihydroxyphenylacetaldehyde, a Toxic Dopaminergic Metabolite, to a Semiquinone Radical and an ortho-Quinone
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M111.249532
– volume: 62
  start-page: 917
  year: 2005
  end-page: 921
  ident: CR20
  article-title: Expression profiling of substantia nigra in Parkinson’s disease, progressive supranuclear palsy, and frontotemporal dementia with Parkinsonism
  publication-title: Arch. Neurol.
  doi: 10.1001/archneur.62.6.917
– volume: 149
  start-page: 105229
  year: 2021
  ident: CR104
  article-title: PET imaging reveals early and progressive dopaminergic deficits after intra-striatal injection of preformed alpha-synuclein fibrils in rats
  publication-title: Neurobiol. Dis.
  doi: 10.1016/j.nbd.2020.105229
– volume: 282
  start-page: 13
  year: 2014
  end-page: 22
  ident: CR71
  article-title: The role of D2-autoreceptors in regulating dopamine neuron activity and transmission
  publication-title: Neuroscience
  doi: 10.1016/j.neuroscience.2014.01.025
– volume: 10
  start-page: 1252
  year: 2015
  end-page: 1260
  ident: CR26
  article-title: Progressive aggregation of alpha-synuclein and selective degeneration of lewy inclusion-bearing neurons in a mouse model of parkinsonism
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2015.01.060
– volume: 114
  start-page: 2283
  year: 1991
  end-page: 2301
  ident: CR5
  article-title: Ageing and Parkinson’s disease: substantia nigra regional selectivity
  publication-title: Brain
  doi: 10.1093/brain/114.5.2283
– volume: 354
  start-page: 269
  year: 1999
  end-page: 279
  ident: CR46
  article-title: Synapsins as regulators of neurotransmitter release
  publication-title: Philos. Trans. R. Soc. Lond. B Biol. Sci.
  doi: 10.1098/rstb.1999.0378
– volume: 8
  start-page: 303
  year: 2018
  end-page: 322
  ident: CR113
  article-title: Best practices for generating and using Alpha-Synuclein pre-formed fibrils to model Parkinson’s disease in rodents
  publication-title: J. Parkinsons Dis.
  doi: 10.3233/JPD-171248
– volume: 89
  start-page: 41
  year: 2021
  end-page: 47
  ident: CR29
  article-title: Preformed fibrils generated from mouse alpha-synuclein produce more inclusion pathology in rats than fibrils generated from rat alpha-synuclein
  publication-title: Parkinsonism Relat. Disord.
  doi: 10.1016/j.parkreldis.2021.06.010
– volume: 867
  start-page: 125
  year: 2015
  end-page: 143
  ident: CR110
  article-title: Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects
  publication-title: Adv. Exp. Med Biol.
  doi: 10.1007/978-94-017-7215-0_9
– ident: CR119
– volume: 67
  start-page: 715
  year: 2010
  end-page: 725
  ident: CR9
  article-title: Clinical progression in Parkinson’s disease and the neurobiology of axons
  publication-title: Ann. Neurol.
  doi: 10.1002/ana.21995
– volume: 112
  start-page: 9596
  year: 2015
  end-page: 9601
  ident: CR88
  article-title: KTKEGV repeat motifs are key mediators of normal α-synuclein tetramerization: Their mutation causes excess monomers and neurotoxicity
  publication-title: Proc. Natl Acad. Sci.
  doi: 10.1073/pnas.1505953112
– volume: 11
  start-page: 213
  year: 2018
  ident: CR48
  article-title: New Insights Into Interactions of Presynaptic Calcium Channel Subtypes and SNARE Proteins in Neurotransmitter Release
  publication-title: Front. Mol. Neurosci.
  doi: 10.3389/fnmol.2018.00213
– volume: 151
  start-page: 83
  year: 1997
  end-page: 87
  ident: CR7
  article-title: Correlation between neuromorphometry in the substantia nigra and clinical features in Parkinson’s disease using disector counts
  publication-title: J. Neurol. Sci.
  doi: 10.1016/S0022-510X(97)00100-7
– volume: 25
  start-page: 2231
  year: 2017
  end-page: 2235
  ident: CR23
  article-title: Alpha-Synuclein mRNA is not increased in Sporadic PD and Alpha-Synuclein accumulation does not block GDNF signaling in Parkinson’s disease and disease models
  publication-title: Mol. Ther.
  doi: 10.1016/j.ymthe.2017.04.018
– volume: 6
  start-page: 8
  year: 2008
  ident: CR98
  article-title: Proteome analysis of human substantia nigra in Parkinson’s disease
  publication-title: Proteome Sci.
  doi: 10.1186/1477-5956-6-8
– volume: 7
  start-page: 35
  year: 2021
  ident: CR22
  article-title: Synucleinopathy-associated pathogenesis in Parkinson’s disease and the potential for brain-derived neurotrophic factor
  publication-title: NPJ Parkinsons Dis.
  doi: 10.1038/s41531-021-00179-6
– volume: 45
  start-page: 462
  year: 2012
  end-page: 468
  ident: CR11
  article-title: Microarray expression analysis in idiopathic and LRRK2-associated Parkinson’s disease
  publication-title: Neurobiol. Dis.
  doi: 10.1016/j.nbd.2011.08.033
– volume: 290
  start-page: 27660
  year: 2015
  end-page: 27679
  ident: CR89
  article-title: Oligomerization and membrane-binding properties of covalent adducts formed by the interaction of α-Synuclein with the Toxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde (DOPAL)
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M115.686584
– volume: 82
  start-page: 185
  year: 2015
  end-page: 199
  ident: CR25
  article-title: Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration
  publication-title: Neurobiol. Dis.
  doi: 10.1016/j.nbd.2015.06.003
– volume: 27
  start-page: 1405
  year: 2007
  end-page: 1410
  ident: CR57
  article-title: Presynaptic -Synuclein aggregates, not lewy bodies, cause neurodegeneration in dementia with lewy bodies
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.4564-06.2007
– volume: 80
  start-page: 675
  year: 2013
  end-page: 690
  ident: CR51
  article-title: Neurotransmitter release: The last millisecond in the life of a synaptic vesicle
  publication-title: Neuron
  doi: 10.1016/j.neuron.2013.10.022
– volume: 18
  start-page: 703
  year: 2011
  end-page: 710
  ident: CR99
  article-title: Catechols in post-mortem brain of patients with Parkinson’s disease
  publication-title: Eur. J. Neurol.
  doi: 10.1111/j.1468-1331.2010.03246.x
– volume: 14
  start-page: 417
  year: 2017
  end-page: 419
  ident: CR120
  article-title: Salmon provides fast and bias-aware quantification of transcript expression
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.4197
– volume: 17
  year: 2020
  ident: CR34
  article-title: Astrocytes can act as antigen-presenting cells in the Parkinson’s disease brain
  publication-title: J. Neuroinflammation
  doi: 10.1186/s12974-020-01776-7
– volume: 32
  start-page: 471
  year: 2011
  end-page: 477
  ident: CR85
  article-title: Inhibition and covalent modification of tyrosine hydroxylase by 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite
  publication-title: Neurotoxicology
  doi: 10.1016/j.neuro.2011.03.013
– volume: 20
  start-page: 125
  year: 1997
  end-page: 156
  ident: CR69
  article-title: The role of vesicular transport proteins in synaptic transmission and neural degeneration
  publication-title: Annu Rev. Neurosci.
  doi: 10.1146/annurev.neuro.20.1.125
– volume: 2
  year: 2005
  ident: CR33
  article-title: Microglial inflammation in the Parkinsonian substantia nigra: relationship to alpha-synuclein deposition
  publication-title: J. Neuroinflammation
  doi: 10.1186/1742-2094-2-14
– volume: 7
  start-page: 139
  year: 2006
  end-page: 148
  ident: CR15
  article-title: Transcriptome analysis reveals link between proteasomal and mitochondrial pathways in Parkinson’s disease
  publication-title: Neurogenetics
  doi: 10.1007/s10048-006-0033-5
– volume: 136
  start-page: 2419
  year: 2013
  end-page: 2431
  ident: CR82
  article-title: Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease
  publication-title: Brain
  doi: 10.1093/brain/awt192
– volume: 9
  start-page: 501
  year: 2019
  end-page: 515
  ident: CR108
  article-title: Parkinson’s disease in women and men: what’s the difference?
  publication-title: J. Parkinsons Dis.
  doi: 10.3233/JPD-191683
– volume: 56
  start-page: 532
  year: 2004
  end-page: 539
  ident: CR8
  article-title: Parkinsonian signs and substantia nigra neuron density in decendents elders without PD
  publication-title: Ann. Neurol.
  doi: 10.1002/ana.20226
– volume: 109
  start-page: 3213
  year: 2012
  end-page: 3219
  ident: CR78
  article-title: Impaired neurotransmission caused by overexpression of α-synuclein in nigral dopamine neurons
  publication-title: Proc. Natl Acad. Sci.
  doi: 10.1073/pnas.1200575109
– volume: 141
  start-page: 582
  year: 2018
  end-page: 595
  ident: CR59
  article-title: Synaptic markers of cognitive decline in neurodegenerative diseases: a proteomic approach
  publication-title: Brain
  doi: 10.1093/brain/awx352
– volume: 79
  start-page: 366
  year: 2016
  end-page: 378
  ident: CR19
  article-title: Mitochondrial DNA depletion in respiratory chain-deficient Parkinson disease neurons
  publication-title: Ann. Neurol.
  doi: 10.1002/ana.24571
– volume: 167
  start-page: 566
  year: 2016
  end-page: 580.e19
  ident: CR39
  article-title: Molecular diversity of midbrain development in mouse, human, and stem
  publication-title: Cells Cell
  doi: 10.1016/j.cell.2016.09.027
– volume: 3
  year: 2006
  ident: CR102
  article-title: Complement activation in the Parkinson’s disease substantia nigra: an immunocytochemical study
  publication-title: J. Neuroinflammation
  doi: 10.1186/1742-2094-3-29
– volume: 14
  start-page: 687
  year: 2017
  end-page: 690
  ident: CR122
  article-title: Differential analysis of RNA-seq incorporating quantification uncertainty
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.4324
– volume: 114
  start-page: E3679
  year: 2017
  end-page: E3688
  ident: CR56
  article-title: Defective synaptic connectivity and axonal neuropathology in a human iPSC-based model of familial Parkinson’s disease
  publication-title: Proc. Natl Acad. Sci.
  doi: 10.1073/pnas.1617259114
– volume: 7
  year: 2017
  ident: CR95
  article-title: DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function
  publication-title: Sci. Rep.
  doi: 10.1038/srep40699
– volume: 291
  start-page: 18675
  year: 2016
  end-page: 18688
  ident: CR116
  article-title: The effect of fragmented pathogenic alpha-Synuclein seeds on prion-like propagation
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M116.734707
– volume: 17
  start-page: e1009364
  year: 2021
  ident: CR73
  article-title: The critical balance between dopamine D2 receptor and RGS for the sensitive detection of a transient decay in dopamine signal
  publication-title: PLoS Comput. Biol.
  doi: 10.1371/journal.pcbi.1009364
– volume: 9
  start-page: 671
  year: 2012
  end-page: 675
  ident: CR118
  article-title: NIH Image to ImageJ: 25 years of image analysis
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.2089
– volume: 41
  start-page: 2039
  year: 2021
  end-page: 2052
  ident: CR30
  article-title: Striatal afferent BDNF is disrupted by Synucleinopathy and partially restored by STN DBS
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.1952-20.2020
– volume: 569
  start-page: 27
  year: 2014
  end-page: 32
  ident: CR93
  article-title: Divalent metal ions enhance DOPAL-induced oligomerization of alpha-synuclein
  publication-title: Neurosci. Lett.
  doi: 10.1016/j.neulet.2014.03.016
– volume: 49
  start-page: 764
  year: 2013
  end-page: 766
  ident: CR125
  article-title: Detecting outliers: Do not use standard deviation around the mean, use absolute deviation around the median
  publication-title: J. Exp. Soc. Psychol.
  doi: 10.1016/j.jesp.2013.03.013
– volume: 2
  start-page: 12
  year: 2016
  end-page: 17
  ident: CR111
  article-title: Progress in the biological function of alpha-enolase
  publication-title: Anim. Nutr.
  doi: 10.1016/j.aninu.2016.02.005
– volume: 335
  start-page: 948
  year: 1990
  end-page: 949
  ident: CR3
  article-title: Parkinson’s disease
  publication-title: Lancet
  doi: 10.1016/0140-6736(90)91006-V
– volume: 26
  start-page: 606
  year: 2007
  end-page: 614
  ident: CR12
  article-title: Effects of gender on nigral gene expression and Parkinson disease
  publication-title: Neurobiol. Dis.
  doi: 10.1016/j.nbd.2007.02.009
– volume: 70
  start-page: 935
  year: 2022
  end-page: 960
  ident: CR36
  article-title: Neurodegeneration and neuroinflammation are linked, but independent of alpha‐synuclein inclusions, in a seeding/spreading mouse model of Parkinson’s disease
  publication-title: Glia
  doi: 10.1002/glia.24149
– volume: 170
  start-page: 330
  year: 2021
  end-page: 340
  ident: CR37
  article-title: Glial activation precedes alpha-synuclein pathology in a mouse model of Parkinson’s disease
  publication-title: Neurosci. Res
  doi: 10.1016/j.neures.2020.11.004
– volume: 16
  year: 2019
  ident: CR35
  article-title: Intrastriatal injection of preformed alpha-synuclein fibrils alters central and peripheral immune cell profiles in non-transgenic mice
  publication-title: J. Neuroinflammation
  doi: 10.1186/s12974-019-1636-8
– volume: 107
  start-page: 7066
  year: 2010
  end-page: 7071
  ident: CR72
  article-title: Regulators of G-protein signaling accelerate GPCR signaling kinetics and govern sensitivity solely by accelerating GTPase activity
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.0912934107
– volume: 1723
  start-page: 335
  year: 2018
  end-page: 360
  ident: CR14
  article-title: Cell-Specific RNA Quantification in Human SN DA neurons from heterogeneous post-mortem midbrain samples by UV-Laser Microdissection and RT-qPCR
  publication-title: Methods Mol. Biol.
  doi: 10.1007/978-1-4939-7558-7_19
– volume: 99
  start-page: 1188
  year: 2006
  end-page: 1196
  ident: CR67
  article-title: Alpha-synuclein inhibits aromatic amino acid decarboxylase activity in dopaminergic cells
  publication-title: J. Neurochem
  doi: 10.1111/j.1471-4159.2006.04146.x
– volume: 113
  start-page: E1108
  year: 2016
  end-page: E1115
  ident: CR50
  article-title: Time-coded neurotransmitter release at excitatory and inhibitory synapses
  publication-title: Proc. Natl Acad. Sci.
  doi: 10.1073/pnas.1525591113
– volume: 54
  start-page: 30
  year: 1991
  end-page: 33
  ident: CR10
  article-title: The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson’s disease estimated with an unbiased stereological method
  publication-title: J. Neurol. Neurosurg. Psychiatry
  doi: 10.1136/jnnp.54.1.30
– volume: 71
  start-page: 1790
  year: 2008
  end-page: 1795
  ident: CR4
  article-title: Progression of dopaminergic dysfunction in a LRRK2 kindred: A multitracer PET study
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000335973.66333.58
– volume: 9
  start-page: 930
  year: 2014
  end-page: 943
  ident: CR40
  article-title: Defining midbrain dopaminergic neuron diversity by single-cell gene expression profiling
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2014.10.008
– volume: 85
  start-page: 206
  year: 2016
  end-page: 217
  ident: CR54
  article-title: Severely impaired hippocampal neurogenesis associates with an early serotonergic deficit in a BAC α-synuclein transgenic rat model of Parkinson’s disease
  publication-title: Neurobiol. Dis.
  doi: 10.1016/j.nbd.2015.10.021
– volume: 123
  start-page: 932
  year: 2012
  end-page: 943
  ident: CR91
  article-title: Vesicular uptake blockade generates the toxic dopamine metabolite 3,4-dihydroxyphenylacetaldehyde in PC12 cells: relevance to the pathogenesis of Parkinson’s disease
  publication-title: J. Neurochem
  doi: 10.1111/j.1471-4159.2012.07924.x
– volume: 117
  start-page: 4971
  year: 2020
  end-page: 4982
  ident: CR31
  article-title: The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration
  publication-title: Proc. Natl Acad. Sci.
  doi: 10.1073/pnas.1913904117
– volume: 43
  start-page: 155
  year: 2020
  end-page: 169
  ident: CR41
  article-title: Classification of midbrain Dopamine neurons using single-cell gene expression profiling approaches
  publication-title: Trends Neurosci.
  doi: 10.1016/j.tins.2020.01.004
– volume: 21
  start-page: 431
  year: 2006
  end-page: 443
  ident: CR80
  article-title: Locomotor hyperactivity and alterations in dopamine neurotransmission are associated with overexpression of A53T mutant human α-synuclein in mice
  publication-title: Neurobiol. Dis.
  doi: 10.1016/j.nbd.2005.08.005
– volume: 10
  start-page: 1593
  year: 2022
  ident: CR49
  article-title: Mechanisms of synaptic vesicle exo- and endocytosis
  publication-title: Biomedicines
  doi: 10.3390/biomedicines10071593
– volume: 5
  start-page: e11464
  year: 2010
  ident: CR76
  article-title: A53T-Alpha-Synuclein overexpression impairs Dopamine signaling and striatal synaptic plasticity in old mice
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0011464
– volume: 17
  year: 2020
  ident: 620_CR34
  publication-title: J. Neuroinflammation
  doi: 10.1186/s12974-020-01776-7
– volume: 14
  start-page: 637
  year: 2003
  ident: 620_CR96
  publication-title: Neurobiol. Dis.
  doi: 10.1016/j.nbd.2003.09.001
– volume: 170
  start-page: 330
  year: 2021
  ident: 620_CR37
  publication-title: Neurosci. Res
  doi: 10.1016/j.neures.2020.11.004
– volume: 141
  start-page: 582
  year: 2018
  ident: 620_CR59
  publication-title: Brain
  doi: 10.1093/brain/awx352
– volume: 18
  start-page: 703
  year: 2011
  ident: 620_CR99
  publication-title: Eur. J. Neurol.
  doi: 10.1111/j.1468-1331.2010.03246.x
– volume: 70
  start-page: 935
  year: 2022
  ident: 620_CR36
  publication-title: Glia
  doi: 10.1002/glia.24149
– volume: 195
  start-page: 27
  year: 2005
  ident: 620_CR21
  publication-title: Exp. Neurol.
  doi: 10.1016/j.expneurol.2005.04.011
– volume: 5
  start-page: e11464
  year: 2010
  ident: 620_CR76
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0011464
– volume: 569
  start-page: 27
  year: 2014
  ident: 620_CR93
  publication-title: Neurosci. Lett.
  doi: 10.1016/j.neulet.2014.03.016
– volume: 10
  start-page: e0128651
  year: 2015
  ident: 620_CR13
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0128651
– volume: 99
  start-page: 1188
  year: 2006
  ident: 620_CR67
  publication-title: J. Neurochem
  doi: 10.1111/j.1471-4159.2006.04146.x
– volume: 3
  year: 2006
  ident: 620_CR102
  publication-title: J. Neuroinflammation
  doi: 10.1186/1742-2094-3-29
– volume: 112
  start-page: 115
  year: 2006
  ident: 620_CR90
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-006-0096-2
– volume: 105
  start-page: 84
  year: 2017
  ident: 620_CR117
  publication-title: Neurobiol. Dis.
  doi: 10.1016/j.nbd.2017.05.014
– volume: 45
  start-page: 462
  year: 2012
  ident: 620_CR11
  publication-title: Neurobiol. Dis.
  doi: 10.1016/j.nbd.2011.08.033
– volume: 27
  start-page: 1405
  year: 2007
  ident: 620_CR57
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.4564-06.2007
– volume: 14
  start-page: 1115
  year: 2014
  ident: 620_CR70
  publication-title: Expert Rev. Neurother.
  doi: 10.1586/14737175.2014.960399
– volume: 54
  start-page: 30
  year: 1991
  ident: 620_CR10
  publication-title: J. Neurol. Neurosurg. Psychiatry
  doi: 10.1136/jnnp.54.1.30
– volume: 112
  start-page: 9596
  year: 2015
  ident: 620_CR88
  publication-title: Proc. Natl Acad. Sci.
  doi: 10.1073/pnas.1505953112
– volume: 63
  start-page: 584
  year: 2006
  ident: 620_CR6
  publication-title: Arch. Neurol.
  doi: 10.1001/archneur.63.4.584
– volume: 30
  start-page: 8083
  year: 2010
  ident: 620_CR53
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.1091-10.2010
– volume: 291
  start-page: 18675
  year: 2016
  ident: 620_CR116
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M116.734707
– ident: 620_CR68
  doi: 10.1002/mds.29051
– volume: 115
  start-page: 193
  year: 2008
  ident: 620_CR87
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-007-0303-9
– volume: 7
  year: 2017
  ident: 620_CR95
  publication-title: Sci. Rep.
  doi: 10.1038/srep40699
– ident: 620_CR119
  doi: 10.3791/4389
– volume: 20
  start-page: 125
  year: 1997
  ident: 620_CR69
  publication-title: Annu Rev. Neurosci.
  doi: 10.1146/annurev.neuro.20.1.125
– volume: 2
  start-page: 12
  year: 2016
  ident: 620_CR111
  publication-title: Anim. Nutr.
  doi: 10.1016/j.aninu.2016.02.005
– volume: 117
  start-page: 4971
  year: 2020
  ident: 620_CR31
  publication-title: Proc. Natl Acad. Sci.
  doi: 10.1073/pnas.1913904117
– volume: 8
  start-page: 303
  year: 2018
  ident: 620_CR113
  publication-title: J. Parkinsons Dis.
  doi: 10.3233/JPD-171248
– volume: 9
  start-page: 671
  year: 2012
  ident: 620_CR118
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.2089
– volume: 8
  start-page: 61
  year: 2022
  ident: 620_CR124
  publication-title: NPJ Parkinsons Dis.
  doi: 10.1038/s41531-022-00322-x
– volume: 109
  start-page: 3213
  year: 2012
  ident: 620_CR78
  publication-title: Proc. Natl Acad. Sci.
  doi: 10.1073/pnas.1200575109
– volume: 7
  start-page: 139
  year: 2006
  ident: 620_CR15
  publication-title: Neurogenetics
  doi: 10.1007/s10048-006-0033-5
– volume: 22
  start-page: 3090
  year: 2002
  ident: 620_CR66
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.22-08-03090.2002
– volume: 13
  start-page: S242
  year: 2007
  ident: 620_CR97
  publication-title: Parkinsonism Relat. Disord.
  doi: 10.1016/S1353-8020(08)70009-9
– volume: 7
  start-page: 22
  year: 2021
  ident: 620_CR74
  publication-title: NPJ Parkinsons Dis.
  doi: 10.1038/s41531-021-00161-2
– volume: 111
  start-page: 1543
  year: 2004
  ident: 620_CR17
  publication-title: J. Neural Transm.
  doi: 10.1007/s00702-004-0212-1
– volume: 4
  year: 2011
  ident: 620_CR16
  publication-title: Mol. Brain
  doi: 10.1186/1756-6606-4-43
– volume: 14
  start-page: 687
  year: 2017
  ident: 620_CR122
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.4324
– volume: 90
  start-page: e48
  year: 2018
  ident: 620_CR109
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000004764
– volume: 12
  start-page: 1149
  year: 2016
  ident: 620_CR60
  publication-title: Alzheimer’s Dement.
  doi: 10.1016/j.jalz.2016.04.005
– volume: 55
  start-page: 1358
  year: 2000
  ident: 620_CR107
  publication-title: Neurology
  doi: 10.1212/WNL.55.9.1358
– volume: 123
  start-page: 932
  year: 2012
  ident: 620_CR91
  publication-title: J. Neurochem
  doi: 10.1111/j.1471-4159.2012.07924.x
– volume: 7
  start-page: 35
  year: 2021
  ident: 620_CR22
  publication-title: NPJ Parkinsons Dis.
  doi: 10.1038/s41531-021-00179-6
– volume: 21
  start-page: 366
  year: 2017
  ident: 620_CR106
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2017.09.039
– volume: 89
  start-page: 41
  year: 2021
  ident: 620_CR29
  publication-title: Parkinsonism Relat. Disord.
  doi: 10.1016/j.parkreldis.2021.06.010
– volume: 16
  year: 2019
  ident: 620_CR35
  publication-title: J. Neuroinflammation
  doi: 10.1186/s12974-019-1636-8
– volume: 10
  start-page: 1081
  year: 2019
  ident: 620_CR44
  publication-title: Front Physiol.
  doi: 10.3389/fphys.2019.01081
– volume: 65
  start-page: 66
  year: 2010
  ident: 620_CR55
  publication-title: Neuron
  doi: 10.1016/j.neuron.2009.12.023
– volume: 26
  start-page: 606
  year: 2007
  ident: 620_CR12
  publication-title: Neurobiol. Dis.
  doi: 10.1016/j.nbd.2007.02.009
– volume: 2
  year: 2005
  ident: 620_CR33
  publication-title: J. Neuroinflammation
  doi: 10.1186/1742-2094-2-14
– volume: 72
  start-page: 57
  year: 2011
  ident: 620_CR38
  publication-title: Neuron
  doi: 10.1016/j.neuron.2011.08.033
– volume: 39
  start-page: 889
  year: 2003
  ident: 620_CR1
  publication-title: Neuron
  doi: 10.1016/S0896-6273(03)00568-3
– ident: 620_CR114
  doi: 10.3791/59758
– volume: 541
  start-page: 481
  year: 2017
  ident: 620_CR101
  publication-title: Nature
  doi: 10.1038/nature21029
– volume: 5
  start-page: 85
  year: 2017
  ident: 620_CR103
  publication-title: Acta Neuropathol. Commun.
  doi: 10.1186/s40478-017-0494-9
– volume: 302
  start-page: 841
  year: 2003
  ident: 620_CR100
  publication-title: Science (1979)
– volume: 167
  start-page: 566
  year: 2016
  ident: 620_CR39
  publication-title: Cells Cell
  doi: 10.1016/j.cell.2016.09.027
– volume: 114
  start-page: E3679
  year: 2017
  ident: 620_CR56
  publication-title: Proc. Natl Acad. Sci.
  doi: 10.1073/pnas.1617259114
– volume: 12
  start-page: 179
  year: 2022
  ident: 620_CR52
  publication-title: Biomolecules
  doi: 10.3390/biom12020179
– volume: 164
  start-page: 488
  year: 2009
  ident: 620_CR61
  publication-title: Neuroscience
  doi: 10.1016/j.neuroscience.2009.08.017
– volume: 867
  start-page: 125
  year: 2015
  ident: 620_CR110
  publication-title: Adv. Exp. Med Biol.
  doi: 10.1007/978-94-017-7215-0_9
– volume: 16
  start-page: 284
  year: 2012
  ident: 620_CR123
  publication-title: OMICS
  doi: 10.1089/omi.2011.0118
– volume: 43
  start-page: 155
  year: 2020
  ident: 620_CR41
  publication-title: Trends Neurosci.
  doi: 10.1016/j.tins.2020.01.004
– volume: 121
  start-page: 695
  year: 2011
  ident: 620_CR32
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-011-0815-1
– volume: 151
  start-page: 83
  year: 1997
  ident: 620_CR7
  publication-title: J. Neurol. Sci.
  doi: 10.1016/S0022-510X(97)00100-7
– volume: 80
  start-page: 675
  year: 2013
  ident: 620_CR51
  publication-title: Neuron
  doi: 10.1016/j.neuron.2013.10.022
– volume: 21
  start-page: 431
  year: 2006
  ident: 620_CR80
  publication-title: Neurobiol. Dis.
  doi: 10.1016/j.nbd.2005.08.005
– volume: 11
  start-page: 213
  year: 2018
  ident: 620_CR48
  publication-title: Front. Mol. Neurosci.
  doi: 10.3389/fnmol.2018.00213
– volume: 287
  start-page: 1265
  year: 2000
  ident: 620_CR64
  publication-title: Science
  doi: 10.1126/science.287.5456.1265
– volume: 108
  start-page: 17183
  year: 2011
  ident: 620_CR45
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.1112690108
– volume: 20
  start-page: 681
  year: 2017
  ident: 620_CR94
  publication-title: Nat. Neurosci.
  doi: 10.1038/nn.4529
– volume: 124
  start-page: 3032
  year: 2014
  ident: 620_CR43
  publication-title: J. Clin. Invest
  doi: 10.1172/JCI72176
– volume: 48
  start-page: 8320
  year: 2020
  ident: 620_CR121
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkaa638
– volume: 10
  start-page: 1593
  year: 2022
  ident: 620_CR49
  publication-title: Biomedicines
  doi: 10.3390/biomedicines10071593
– volume: 107
  start-page: 7066
  year: 2010
  ident: 620_CR72
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.0912934107
– volume: 755
  start-page: 363
  year: 2011
  ident: 620_CR18
  publication-title: Methods Mol. Biol.
  doi: 10.1007/978-1-61779-163-5_30
– volume: 1723
  start-page: 335
  year: 2018
  ident: 620_CR14
  publication-title: Methods Mol. Biol.
  doi: 10.1007/978-1-4939-7558-7_19
– volume: 22
  start-page: 2780
  year: 2002
  ident: 620_CR63
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.22-07-02780.2002
– volume: 113
  start-page: E1108
  year: 2016
  ident: 620_CR50
  publication-title: Proc. Natl Acad. Sci.
  doi: 10.1073/pnas.1525591113
– volume: 62
  start-page: 917
  year: 2005
  ident: 620_CR20
  publication-title: Arch. Neurol.
  doi: 10.1001/archneur.62.6.917
– volume: 275
  start-page: 427
  year: 1991
  ident: 620_CR112
  publication-title: Biochem. J.
  doi: 10.1042/bj2750427
– volume: 6
  start-page: 8
  year: 2008
  ident: 620_CR98
  publication-title: Proteome Sci.
  doi: 10.1186/1477-5956-6-8
– volume: 14
  start-page: 417
  year: 2017
  ident: 620_CR120
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.4197
– volume: 32
  start-page: 471
  year: 2011
  ident: 620_CR85
  publication-title: Neurotoxicology
  doi: 10.1016/j.neuro.2011.03.013
– volume: 71
  start-page: 1790
  year: 2008
  ident: 620_CR4
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000335973.66333.58
– volume: 56
  start-page: 532
  year: 2004
  ident: 620_CR8
  publication-title: Ann. Neurol.
  doi: 10.1002/ana.20226
– volume: 989
  start-page: 205
  year: 2003
  ident: 620_CR83
  publication-title: Brain Res
  doi: 10.1016/S0006-8993(03)03354-7
– volume: 282
  start-page: 13
  year: 2014
  ident: 620_CR71
  publication-title: Neuroscience
  doi: 10.1016/j.neuroscience.2014.01.025
– volume: 110
  start-page: E4016
  year: 2013
  ident: 620_CR92
  publication-title: Proc. Natl Acad. Sci.
  doi: 10.1073/pnas.1309143110
– volume: 29
  start-page: 3365
  year: 2009
  ident: 620_CR58
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.5427-08.2009
– volume: 67
  start-page: 715
  year: 2010
  ident: 620_CR9
  publication-title: Ann. Neurol.
  doi: 10.1002/ana.21995
– volume: 47
  start-page: 493
  year: 2000
  ident: 620_CR2
  publication-title: Ann. Neurol.
  doi: 10.1002/1531-8249(200004)47:4<493::AID-ANA13>3.0.CO;2-4
– volume: 85
  start-page: 206
  year: 2016
  ident: 620_CR54
  publication-title: Neurobiol. Dis.
  doi: 10.1016/j.nbd.2015.10.021
– volume: 118
  start-page: 3523
  year: 2005
  ident: 620_CR65
  publication-title: J. Cell Sci.
  doi: 10.1242/jcs.02481
– volume: 15
  year: 2018
  ident: 620_CR27
  publication-title: J. Neuroinflammation
  doi: 10.1186/s12974-018-1171-z
– volume: 9
  start-page: 501
  year: 2019
  ident: 620_CR108
  publication-title: J. Parkinsons Dis.
  doi: 10.3233/JPD-191683
– volume: 174
  start-page: 1015
  year: 2018
  ident: 620_CR42
  publication-title: Cell
  doi: 10.1016/j.cell.2018.07.028
– volume: 130
  start-page: 104525
  year: 2019
  ident: 620_CR28
  publication-title: Neurobiol. Dis.
  doi: 10.1016/j.nbd.2019.104525
– volume: 14
  start-page: 734
  year: 2017
  ident: 620_CR81
  publication-title: Neuroimage Clin.
  doi: 10.1016/j.nicl.2017.03.011
– volume: 149
  start-page: 105229
  year: 2021
  ident: 620_CR104
  publication-title: Neurobiol. Dis.
  doi: 10.1016/j.nbd.2020.105229
– volume: 114
  start-page: 2283
  year: 1991
  ident: 620_CR5
  publication-title: Brain
  doi: 10.1093/brain/114.5.2283
– volume: 9
  start-page: 2135
  year: 2014
  ident: 620_CR115
  publication-title: Nat. Protoc.
  doi: 10.1038/nprot.2014.143
– volume: 82
  start-page: 185
  year: 2015
  ident: 620_CR25
  publication-title: Neurobiol. Dis.
  doi: 10.1016/j.nbd.2015.06.003
– volume: 28
  start-page: 2471
  year: 2008
  ident: 620_CR79
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.3040-07.2008
– volume: 85
  start-page: 957
  year: 2003
  ident: 620_CR62
  publication-title: J. Neurochem
  doi: 10.1046/j.1471-4159.2003.01742.x
– volume: 49
  start-page: 764
  year: 2013
  ident: 620_CR125
  publication-title: J. Exp. Soc. Psychol.
  doi: 10.1016/j.jesp.2013.03.013
– volume: 10
  start-page: 658
  year: 2021
  ident: 620_CR47
  publication-title: Cells
  doi: 10.3390/cells10030658
– volume: 10
  start-page: 1252
  year: 2015
  ident: 620_CR26
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2015.01.060
– volume: 45
  start-page: 1903
  year: 1985
  ident: 620_CR84
  publication-title: J. Neurochem
  doi: 10.1111/j.1471-4159.1985.tb10550.x
– volume: 286
  start-page: 26978
  year: 2011
  ident: 620_CR86
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M111.249532
– volume: 9
  start-page: 930
  year: 2014
  ident: 620_CR40
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2014.10.008
– volume: 79
  start-page: 366
  year: 2016
  ident: 620_CR19
  publication-title: Ann. Neurol.
  doi: 10.1002/ana.24571
– volume: 290
  start-page: 27660
  year: 2015
  ident: 620_CR89
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M115.686584
– volume: 89
  start-page: 1091
  year: 2011
  ident: 620_CR77
  publication-title: J. Neurosci. Res
  doi: 10.1002/jnr.22611
– volume: 25
  start-page: 2231
  year: 2017
  ident: 620_CR23
  publication-title: Mol. Ther.
  doi: 10.1016/j.ymthe.2017.04.018
– volume: 335
  start-page: 948
  year: 1990
  ident: 620_CR3
  publication-title: Lancet
  doi: 10.1016/0140-6736(90)91006-V
– volume: 171
  start-page: 105804
  year: 2022
  ident: 620_CR105
  publication-title: Neurobiol. Dis.
  doi: 10.1016/j.nbd.2022.105804
– volume: 41
  start-page: 2039
  year: 2021
  ident: 620_CR30
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.1952-20.2020
– volume: 17
  start-page: e1009364
  year: 2021
  ident: 620_CR73
  publication-title: PLoS Comput. Biol.
  doi: 10.1371/journal.pcbi.1009364
– volume: 338
  start-page: 949
  year: 2012
  ident: 620_CR24
  publication-title: Science
  doi: 10.1126/science.1227157
– volume: 28
  start-page: 35
  year: 2008
  ident: 620_CR75
  publication-title: Cell Mol. Neurobiol.
  doi: 10.1007/s10571-007-9227-0
– volume: 354
  start-page: 269
  year: 1999
  ident: 620_CR46
  publication-title: Philos. Trans. R. Soc. Lond. B Biol. Sci.
  doi: 10.1098/rstb.1999.0378
– volume: 136
  start-page: 2419
  year: 2013
  ident: 620_CR82
  publication-title: Brain
  doi: 10.1093/brain/awt192
SSID ssj0001468950
Score 2.2709868
Snippet Examination of early phases of synucleinopathy when inclusions are present, but long before neurodegeneration occurs, is critical to both understanding disease...
Abstract Examination of early phases of synucleinopathy when inclusions are present, but long before neurodegeneration occurs, is critical to both...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 7
SubjectTerms 631/378/1689/1718
631/378/548
Biomedical and Life Sciences
Biomedicine
Dopamine
Neurodegeneration
Neurology
Neurosciences
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT9wwELYqDqgXxKOloYCMxK2N2PgV-wgIhJDoqUh7s2zHVldC2YrsHvbfd8bJLmwL5YJyiBLbkTUeZ16ebwg51aPEGuZ8aeqIrpsQS6-EKaNLOEClmKuW3P1QN_fidizHz0p94ZmwHh64J9yZ9k0EGwDESB1FE71HgDSWWArCsRCytQ4y75kxlb0rQmkjR0OWzIjrsw4kFQfLmfES8wZH5WJNEmXA_pe0zH8PS_4VMc2C6HqbbA0aJD3vZ75DPsR2l2zeDTHyPTLO4if_DDDjmPZVueFTdJpoRDxj2i1ahDGetFMsSLygk5YCI3Rwb2ClG4rOWRgXUaGFx4RpAQ_dJ3J_ffXz8qYc6ieUQYpqVrpUhxDruoK1qEWSScHFhakSN945JZln3Kg6KKcaLzRzDBWmyBtutFeefyYb7bSNXwiVBuwaJ43DRFoVgpfKGxV4o0GBqp0uSLWkpQ0DuDjWuHiwOcjNte3pb4H-NtPfLgrybTXmdw-t8d_eF7hEq54Ii51fALPYgVnsW8xSkMPlAtthr3aWGQwGI8pQQU5WzbDLMHTi2jidYx_4dRkuOPTZ7_lhNRPEOAQFAGig1zhlbarrLe3kV0byBtsbNoasCvJ9yVRP83qdFgfvQYuv5CMDBS27k_gh2Zg9zuMRKFgzf5z30h9fGCON
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Springer Nature HAS Fully OA
  dbid: AAJSJ
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3di9QwEA_nHYgv4re9OyWCb1ps89XkcRWPY-F80YN9C0ma6MLRynXvYf97Z9J2j9VTkD6UtpMSJpPMTCbzG0Le6iqxljlfmibi1k2IpVfClNElbKBSzFVLLr6o80uxXMnVAWFzLkw-tJ8hLfMyPZ8O-zCAouHg-DJeYtpfVW7vkSOEagfZPlosll-XtzsrQmkjqylDpuL6jsZ7WiiD9d9lYf55UPK3aGlWQmePyMPJeqSLsb-PyUHsnpD7F1N8_ClZZdWTFwLMNqZjRW74Fe0TjYhlTIdthxDG667HYsRbuu4oCMEA9xZGuaW4MQvtIhqz8JgwJeBqeEYuzz5_-3ReTrUTyiBFvSldakKITVPDODQiyaTg4sLUiRvvnJLMM25UE5RTrReaOYbGUuQtN9orz5-Tw67v4ktCpQGfxknjMIlWheCl8kYF3mownhqnC1LPvLRhAhbH-hZXNge4ubYj_y3w32b-221B3u3a_BxhNf5J_RGHaEeJkNj5RX_93U4iYrVvIziLYG80UbTRe0TSY4mlIBwLoSrI6TzAdpqng2UGA8GIMFSQN7vPMMMwbOK62N8gDSxbhgsONC9Gedj1BPENQfkDD_SepOx1df9Lt_6RUbzB74ZJIeuCvJ-F6rZff-fF8f-Rn5AHDMywvGnET8nh5vomvgIzauNfT_PmFzHNGdo
  priority: 102
  providerName: Springer Nature
Title Transcriptomic profiling of early synucleinopathy in rats induced with preformed fibrils
URI https://link.springer.com/article/10.1038/s41531-023-00620-y
https://www.ncbi.nlm.nih.gov/pubmed/38172128
https://www.proquest.com/docview/2909354043
https://www.proquest.com/docview/2910193433
https://pubmed.ncbi.nlm.nih.gov/PMC10764951
https://doaj.org/article/8bde4016617e4debb09532f2fc4a2cc0
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swEBdbC2MvY9_z2gUP9raZOpIsS08jDS0l0DK2FfImJFlaA8Xu6vQh_33vZCUh-yh-MLYlI9-HdLrz_Y6QT7IMtKHGFqr26LpxvrCCq8KbgB1E8LFqyfmFOLvks3k1Tw63Pv1WuZ4T40TddA595EdUYcgOsWC-3vwusGoURldTCY3HZB-hy1Cq63m99bFwIVVVplyZksmjHtYrBvtnygrMHiyL1c56FGH7_2Vr_v3L5B9x07gcnT4nz5IdmU8Gxr8gj3z7kjw5T5HyV2QeF6E4JWDecT7U5oZX5V3IPaIa5_2qRTDjRdthWeJVvmhzEIcezg3wu8nRRQv9PJq1cBkwOeC6f00uT09-Ts-KVEWhcBUfLwsTaud8XY-BIzUPVRBwMK7GgSlrjKiopUyJ2gkjGsslNRTNJs8apqQVlr0he23X-nckrxTsbkylDKbTCudsJawSjjUSzKjayIyM17TULkGMY6WLax1D3Uzqgf4a6K8j_fUqI583fW4GgI0HWx8jizYtERw73uhuf-mka1raxsO2ESyP2vPGW4uYejTQ4LihzpUZOVwzWCeN7fVWvjLycfMYdA0DKKb13R22gQlMMc6gzdtBHjYjQaRDMAOABnJHUnaGuvukXVxFPG_YgYN6VOOMfFkL1XZc_6fF-4c_44A8pWCARXcROyR7y9s7_wEMqKUdRS0Zkf3JZPZjBufjk4tv3-HuVExH0SlxD7HrH0k
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbtQw0CpFgl4QzzZQIEhwgqiJnTj2ASFe1ZZ2e2qlvRnbsWGlKinNVig_xTcy4yS7Wh69VTlESezIGc97MjOEvBSppxXVJpGlQ9eNdYnhuUyc9jiBexe6lkyP-eQ0_zIrZhvk15gLg79VjjwxMOqqsegj36MSQ3ZYC-bd-Y8Eu0ZhdHVsodGjxaHrfoLJ1r49-AT7-4rS_c8nHyfJ0FUgsUWeLRLtS2tdWWawwjL3hedwsFxmnkmjNS-ooUzy0nLNK5MLqimqEY5VTArDDYP33iA3QfCmaOyVs3Ll08m5kEU65OakTOy1IB8Z2OuUJZitmCbdmvwLbQL-pdv-_YvmH3HaIP7275I7g94av-8R7R7ZcPV9cms6ROYfkFkQeoEFYZ5z3PcCh1fFjY8dVlGO267G4snzusE2yF08r2NAvxbOFeBXFaNLGOY5VKPh0mMywln7kJxeC3wfkc26qd0OiQsJ1pQupMb0XW6tKbiR3LJKgNpWahGRbISlskNJc-yscaZCaJ0J1cNfAfxVgL_qIvJ6Oee8L-hx5egPuEXLkViMO9xoLr6pgbaVMJUDMxU0ndLllTMGa_hRT73NNbU2jcjuuMFq4BCtWuFzRF4sHwNtY8BG1665xDHAMCXLGYzZ7vFhuRKsrAhqB8BArGHK2lLXn9Tz76F-OCAukGORReTNiFSrdf0fFo-v_ozn5PbkZHqkjg6OD5-QLQrKX3BVsV2yubi4dE9BeVuYZ4FiYvL1ukn0N4QXV2Q
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1db9Mw8DQ6aeIF8U3HgCDBE0Rt7cSJHxBibNXGWDUhJvXN2I4NlaZkWzqh_jV-HXdO0qp87G3KQ5TEtpzz3fk-fHcAr_KhZwXTJpaZI9ONdbERiYyd9tRBeBeqlhxPxMFp8mmaTjfgVxcLQ8cqO54YGHVRWbKRD5gklx3lghn49ljEyd74_flFTBWkyNPaldNoUOTILX6i-la_O9zDtX7N2Hj_68eDuK0wENs0Gc1j7TNrXZaNcLZZ4lMv8OKJHHkujdYiZYZxKTIrtChMkjPNSKRwvOAyN8JwHPcWbGakFfVgc3d_cvJlZeFJRC7TYRupM-T5oMbdkqP2znhMsYvDeLG2G4aiAf-SdP8-sPmH1zZshuO7cKeVYqMPDdrdgw1X3oet49ZP_wCmYQsMDIminqOmMjgOFVU-cpRTOaoXJaVSnpUVFUVeRLMyQmSs8V4gthURGYixnyOhGh89hSac1Q_h9EYg_Ah6ZVW6JxClEnUrnUpNwbzCWpMKI4XlRY5CXKbzPow6WCrbJjinOhtnKjjaea4a-CuEvwrwV4s-vFn2OW_Se1zbepeWaNmSUnOHF9Xld9VSuspN4VBpRbknc0nhjKGMfswzbxPNrB32YadbYNXyi1qtsLsPL5efkdLJfaNLV11RG2Sfkicc2zxu8GE5E8qziEIIwiBfw5S1qa5_KWc_QjZx1P-RONNRH952SLWa1_9hsX39b7yALSRP9flwcvQUbjOUBIPdiu9Ab3555Z6hJDc3z1uSieDbTVPpb2UjXP8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Transcriptomic+profiling+of+early+synucleinopathy+in+rats+induced+with+preformed+fibrils&rft.jtitle=NPJ+Parkinson%27s+Disease&rft.au=Patterson%2C+Joseph+R&rft.au=Kochmanski%2C+Joseph&rft.au=Stoll%2C+Anna+C&rft.au=Kubik%2C+Michael&rft.date=2024-01-03&rft.issn=2373-8057&rft.eissn=2373-8057&rft.volume=10&rft.issue=1&rft.spage=7&rft_id=info:doi/10.1038%2Fs41531-023-00620-y&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2373-8057&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2373-8057&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2373-8057&client=summon